Development of gene therapy-based strategies for the treatment of eye diseases

Drug Development Research

Volumn 46, Issue 3-4, 1999, Pages 277-285

  Rakoczy, Piroska E ^a,b   Shen, Wei Yong ^b   Lai, May ^a   Rolling, Fabienne ^b   Constable, Ian J ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b LIONS EYE INSTITUTE   (Australia)

Author keywords

Delivery; Eye; Gene therapy; Retina

Indexed keywords

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD RETINA BARRIER; DNA TRANSFER; EYE DISEASE; GENE EXPRESSION REGULATION; GENE THERAPY; NONHUMAN; PIGMENT EPITHELIUM; RAT; RETINA CELL;

EID: 0033038676     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2299(199903/04)46:3/4<277::AID-DDR13>3.0.CO;2-B     Document Type: Article

References (53)

1. Afione SA, Conrad CK, Kearns WG, Chunduru S, Adams R, Reynolds TC, Guggino WB, Cutting GR, Carter BJ, Flotte TR. 1996. In vivo model of adeno-associated virus vector persistence and rescue. J Viral 70:3235-3241.
2. Ali M, Lemoine NR, Ring CJA. 1994. The use of DNA viruses as vectors for gene therapy. Gene Ther 1:367-384.
3. Bennett J, Wilson J, Sun D, Forbes B, Maguire A. 1994. Adenovirus vector-mediated in vivo gene transfer into adult murine retina. Invest Ophthalmol Vis Sci 35:2535-2542.
4. Bennett J, Tanabe T, Sun D, Zeng Y, Kjeldbye H, Gouras P, Maguire AM. 1996a. Photoreceptor cell rescue in retinal degeneration (rd) mice by in vivo gene therapy. Nat Med 2:649-654.
5. Bennett J, Pakola S, Zeng Y, Maguire A. 1996b. Humoral response after administration of E1-deleted adenoviruses: immune privilege of the subretinal space. Hum Gene Ther 7:1763-1769.
6. Bennett J, Duan D, Engelhardt JF, Maguire A. 1997. Real-time noninvasive in vivo assessment of adeno-associated virus-mediated retinal transduction. Invest Ophthalmol Vis Sci 38:2857-2863.
7. Bergelson JM, Cunningham JA, Droguett G, Kurt-Jones EA, Krithivas A, Hong JS, Horwitz MS, Crowell RL, Finberg RW. 1997. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science 275:1320-1323.
8. Bok D, Young RW 1979. Phagocytic properties of the retinal pigment epithelium. In: Zinn KM, Marmor MF, editors. The retinal pigment epithelium. London: Harvard University Press. p 148-174.
9. Cook B, Lewis GP, Fisher SK, Adler R. 1995. Apoptotic photoreceptor degeneration in experimental retinal detachment. Invest Ophthalmol Vis Sci 36:990-996.
10. DiLoreto D, Grover DA, Del Cerro C, Del Cerro M. 1994. A new procedure for fundus photography and fluorescein angiography in small laboratory animal eyes. Curr Eye Res 13:157-161.
11. Evans J, Wormald R. 1996. Is the incidence of registrable age-related macular degeneration increasing? Br J Ophthalmol 80:9-14.
12. Feemaki M, Barrazzaortiz X, Adams R, Askin FB, Carter BJ, Guggino WB, Flotte TR. 1996. Safety of single-dose administration of an adeno-associated virus (AAV)-cftr vector in the primate lung. Gene Ther 3:658-668.
13. Finnemann SC, Bonilha VL, Marmorstein AD, Rodriguez-Boulan E. 1997. Phagocytosis of rod outer segments by retinal pigment epithelial cells requires avb5 integrin for binding but not for internalization. Proc Natl Acad Sci USA 94:12932-12937,
14. Fisher KJ, Joos K, Alston J, Yang YP, Haecker SE, High K, Pathak R, Raper SE, Wilson JM. 1997. Recombinant adeno-associated virus for muscle directed gene therapy. Nat Med 3:306-312.
15. Flannery JG, Zolotukhin S, Vaquero MI, LaVail MM. 1997. Efficient photoreceptor-targeted gene expression in vivo by recombinant adeno-associated virus. Proc Natl Acad Sci USA 94:6916-6921.
16. Goldman MJ, Wilson JM. 1995. Expression of alpha (Nu) beta (5) integrin is necessary for efficient adenovirus-mediated gene transfer in the human airway. J Virol 69:5951-5958.
17. Grant CA, Ponnazhagan S, Shan-Wang X, Srivastava A, Li T. 1997. Evaluation of recombinant adeno-associated virus as a gene transfer vector for the retina. Curr Eye Res 949-956.
18. Greber UF, Willetts M, Webster P, Helenius A. 1993. Stepwise dismantling of adenovirus 2 during entry into cells. Cell 75:477-486.
19. Joos K, Yang Y, Fisher KJ, Wilson JM. 1998. Transduction of dendritic cells by DNA viral vectors directs the immune response to transgene products in muscle fibers. J Virol 72:4212-4223.
20. Kelly TJ, Lewis AM. 1973. Use of non-defective adenovirus-simian virus 40 hybrids for mapping the SV40 genome. J Virol 12:643-652.
21. Kertes PJ, Peyman GA. 1997. Drainage of subretinal fluid under silicone oil. Can J Ophthalmol 32:445-446.
22. Kotin RM, Siniscalco M, Samulski RJ, Zhu XD, Hunter L, Laughlin CA, McLaughlin S, Muzyczka N, Rocchi M, Berns KI. 1990. Site-specific integration by adeno-associated virus. Proc Natl Acad Sci USA 87:2211-2215.
23. Kotin RM, Linden RM, Berns KI. 1992. Characterization of a preferred site on human chromosome 19q for integration of adeno-associated virus DNA by non-homologous recombination. EMBO J 11:5071-5078.
24. Lamartina S, Roscilli G, Rinaudo D, Delmastro P, Tonialti C. 1998. Lipofection of purified adeno-associated vims REP68 protein - toward a chromosome-targeting nonviral particle. J Virol 72(9):7653-7658.
25. Li T, Adamian M, Roof DJ, Berson EL, Dryja TP, Roessler BJ, Davidson BL. 1994. In vivo transfer of a reporter gene to the retina mediated by an adenoviral virus. Invest Ophthalmol Vis Sci 35:2543-2549.
26. Lonberg-Holm K, Philipson L. 1969. Early events of virus-cell interaction in an adenovirus system. J Virol 4:328-338.
27. Mashhour B, Couton D, Perricaudet M, Briand P. 1994. In vivo adenovirus-mediated gene transfer into ocular tissues. Gene Ther 1:122-126.
28. Monahan PE, Samulski RJ, Tazelaar J, Xiao X, Nichols TC, Bellinger DA, Read MS, Walsh CE. 1998. Direct intramusclar injection with recombinant aav vectors results in sustained expression in a dog model of hemophilia. Gene Ther 5:40-49.
29. Nevins JR. 1981. Mechanisms of activation of early viral transcription by the adenovirus E1a gene product. Cell 26:213-220.
30. Nevins JR, Imperiale MJ, Kao HT, Strickland S, Feldman LT. 1984. Detection of an adenovirus E1 a-like activity in mammalian cells. Curr Top Microbiol Immunol 113:15-19.
31. Okada H, Miyamura K, Itoh T, Hagiwara M, Wakabayashi T, Mizuno M, Colosi P, Kurtzman G, Yoshida J. 1996. Gene therapy against an experimental glioma using adeno-associated virus vectors. Gene Ther 3:957-964.
32. Petersen J, Meyer-Riemann W, Ritzau-Tondrow U, Bahlmann D. 1998. Visual fields after removal of subretinal hemorrhages and neovascular membranes in age-related macular degeneration. Graefe's Arch Clin Exp Ophthalmol 236:241-247.
33. Philipson L, Lonberg-Holm K, Pettersson U. 1968. Virus-receptor interaction in an adenovirus system. J Virol 2:1064-1075.
34. Podsakoff G, Wong KK, Chatterjee S. 1994. Efficient gene transfer into nondividing cells by adeno-associated virus-based vectors. J Virol 68:5656-5666.
35. Reichel MB, Ali RR, Thrasher AJ, Hunt DM, Bhattacharya SS, Baker D. 1998. Immune responses limit adenovirally mediated gene expression in the adult mouse eye. Gene Ther 5:1038-1046.
36. Rolling F, Nong Z, Pisvin S, Collen D. 1997. Adeno-associated virus-mediated gene transfer into rat carotid arteries. Gene Ther 4:757-761.
37. Ruben M, Bacchetti S, Graham FL. 1982. Integration and expression of viral DNA in cells transformed by host range mutants of adenovirus type 5. J Virol 41:674-685.
38. Saika S, Yamanaka A, Minamide A, Kin K, Shirai K, Tanaka S, Kawashima Y, Katoh T, Okada Y, Ohkawa K et al. 1998. Subretinal administration of tissue-type plasminogen activator to speed the drainage of subretinal hemorrhage. Graefe's Arch Clin Exp Ophthalmol 236:196-201.
39. Sakamoto T, Ueno H, Goto Y, Oshima Y, Ishibashi T, Inomata H. 1998. A vitrectomy improves the transfection efficiency of adenoviral vector-mediated gene transfer to Muller cells. Gene Ther 5:1088-1097.
40. Salmons B, Gunzburg WH. 1993. Targeting of retroviral vectors for gene therapy. Hum Gene Ther 4:129-141.
41. Samulski RJ, Zhu X, Xiao X, Brook JD, Housman DE, Epstein N, Hunter LA. 1991. Targeted integration of adeno-associated virus (AAV) into human chromosome 19. EMBO J 10:3941-3950.
42. Schiedner G, Morral N, Parks RJ, Wu Y, Koopmans SC, Langston C, Graham FL, Beaudet AL, Kochanek S. 1998. Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity. Nat Genet 18:180-183.
43. Shen W, Yu M, Barry C, Constable IJ, Rakoczy PE. 1998. Expression of cell adhesion molecules and vascular endothelial growth factor in experimental choroidal neovascularisation in the rat. Br J Ophthalmol 82:1063-1071.
44. Sikora K. (1996) Gene therapy. BIOS Scientific Publishers.
45. Spetzger U, Gilsback JM, Mosges R, Schlondroff G, Laborde G. 1997. The computer assisted localizer, a navigational help in microneurosurgery. Eur Surg Res 29:481-487.
46. Stramm LE, Wolfe JH, Schuchman EH, Haskins ME, Patterson DF, Aguirre GD. 1990. b-Glueuronidase mediated pathway essential for retinal pigment epithelial degradation of glycosaminoglycans. Disease expression and in vitro disease correction using retroviral mediated cDNA transfer. Exp Eye Res 50:521-532.
47. Summerford C, Samulski RJ. 1998. Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions. J Virol 72:1438-1445.
48. Tsukamoto K, Smith P, Glick JM, Rader DJ. 1997. Liver-directed gene transfer and prolonged expression of three major human ApoE isoforms in ApoE-deficient mice. J Clin Invest 100:107-114.
49. Varga MJ, Weibull C, Everitt E. 1991. Infectious entry pathway of adenovirus type 2. J Virol 65:6061-6070.
50. Xiao X, Samulski RJ. 1996. Long-term and efficient in vivo gene transfer into muscle tissue of immunocompetent mice with rAAV vector. J Virol 70:8098-8108.
51. Yang Y, Nunes FA, Berencsi K, Gonczol E, Englehardt JF, Wilson JM. 1994. Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis. Nat Genet 7:362-369.
52. Yu D, Cringle SJ, Constable IJ. 1998. Robotic ocular ultramicrosurgery. Aust NZ J Ophthalmol 26:S6-8.
53. Zhang W, Koch PE, Roth JA. 1995. Detection of wild-type contamination in a recombinant adenoviral preparation by PCR. Biotechniques 18:444-446.